drugset / Trial / NCT04121780

Growth Hormone Replacement Therapy for Retried Professional Football Players

NCT04121780

RandomizedParallel-groupTriple-blindTreatment

Summary

This is a randomized, double-blind, placebo-controlled, parallel-group trial with an open-label extension to evaluate the efficacy of growth hormone (GH) on cognitive functions of retired professional football players with growth hormone deficiency (GHD).

Timeline

Start
2019-10-08
Primary completion
2025-03
Completion
2026-09

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Somatropin Protein / enzyme biologic